{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:19:42Z","timestamp":1793859582287,"version":"4.6.1"},"reference-count":179,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s12035-022-03193-8","type":"journal-article","created":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T21:03:00Z","timestamp":1672693380000},"page":"1929-1948","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":176,"title":["Rotenone-Induced Model of Parkinson\u2019s Disease: Beyond Mitochondrial Complex I Inhibition"],"prefix":"10.1007","volume":"60","author":[{"given":"Mar\u00eda Teresa","family":"Ibarra-Guti\u00e9rrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5859-2617","authenticated-orcid":false,"given":"Norma","family":"Serrano-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7388-3738","authenticated-orcid":false,"given":"Marisol","family":"Orozco-Ibarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,3]]},"reference":[{"key":"3193_CR1","unstructured":"World Health Organization (2021) Ageing and health.\nRecovered\nfrom\u00a0https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/ageing-and-health. Accessed 1 Oct 2021"},{"issue":"5","key":"3193_CR2","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1212\/01.wnl.0000252807.38124.a3","volume":"68","author":"D Hirtz","year":"2007","unstructured":"Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky ARR (2007) How common are the \u201ccommon\u201d neurologic disorders? Neurology 68(5):326\u2013337. https:\/\/doi.org\/10.1212\/01.wnl.0000252807.38124.a3","journal-title":"Neurology"},{"key":"3193_CR3","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/mds.27115","volume":"32","author":"JA Obeso","year":"2017","unstructured":"Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE et al (2017) Past, present, and future of Parkinson\u2019s disease: a special essay on the 200th Anniversary of the Shaking Palsy. Mov Disord 32:1264\u20131310. https:\/\/doi.org\/10.1002\/mds.27115","journal-title":"Mov Disord"},{"key":"3193_CR4","first-page":"S1","volume":"1","author":"K Wirdefeldt","year":"2011","unstructured":"Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J (2011) Epidemiology and etiology of Parkinson\u2019s disease: a review of the evidence. Eur J Epidemiol Suppl 1:S1-58","journal-title":"Eur J Epidemiol Suppl"},{"issue":"15","key":"3193_CR5","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P et al (2008) Movement Disorder Society UPDRS Revision Task Force. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23(15):2129\u20132170. https:\/\/doi.org\/10.1002\/mds.22340","journal-title":"Mov Disord"},{"issue":"2","key":"3193_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24(2):197\u2013211. https:\/\/doi.org\/10.1016\/s0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"key":"3193_CR7","doi-asserted-by":"publisher","unstructured":"Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, R\u00fcb U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson\u2019s disease (preclinical and clinical stages). J Neurol. 249 Suppl 3:III\/1\u20135. https:\/\/doi.org\/10.1007\/s00415-002-1301-4","DOI":"10.1007\/s00415-002-1301-4"},{"issue":"1","key":"3193_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","volume":"396","author":"H Braak","year":"2006","unstructured":"Braak H, de Vos RA, Bohl J, Del Tredici K (2006) Gastric alpha-synuclein immunoreactive inclusions in Meissner\u2019s and Auerbach\u2019s plexuses in cases staged for Parkinson\u2019s disease-related brain pathology. Neurosci Lett 396(1):67\u201372. https:\/\/doi.org\/10.1016\/j.neulet.2005.11.012","journal-title":"Neurosci Lett"},{"key":"3193_CR9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.compbiomed.2018.09.008","volume":"102","author":"S Bhat","year":"2018","unstructured":"Bhat S, Acharya UR, Hagiwara Y, Dadmehr N, Adeli H (2018) Parkinson\u2019s disease: cause factors, measurable indicators, and early diagnosis. Comput Biol Med 102:234\u2013241. https:\/\/doi.org\/10.1016\/j.compbiomed.2018.09.008","journal-title":"Comput Biol Med"},{"issue":"4","key":"3193_CR10","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000445751","volume":"46","author":"L Hirsch","year":"2016","unstructured":"Hirsch L, Jette N, Frolkis A, Steeves T, Pringsheim T (2016) The incidence of Parkinson\u2019s disease: a systematic review and meta-analysis. Neuroepidemiology 46(4):292\u2013300. https:\/\/doi.org\/10.1159\/000445751","journal-title":"Neuroepidemiology"},{"key":"3193_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.parkreldis.2019.06.025","volume":"67","author":"N Niemann","year":"2019","unstructured":"Niemann N, Jankovic J (2019) Juvenile parkinsonism: Differential diagnosis, genetics, and treatment. Parkinsonism Relat Disord 67:74\u201389. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.06.025","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"3193_CR12","doi-asserted-by":"publisher","first-page":"6661","DOI":"10.1007\/s00415-022-11278-6","volume":"269","author":"L Magistrelli","year":"2022","unstructured":"Magistrelli L, Contaldi E, Milner AV, Gallo S, Sacchetti M, Fornaro R, Cantello R, Comi C (2022) A very early onset of juvenile parkinsonism. J Neurol 269(12):6661\u20136663. https:\/\/doi.org\/10.1007\/s00415-022-11278-6","journal-title":"J Neurol"},{"key":"3193_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.yfrne.2016.09.003","volume":"43","author":"JL Labandeira-Garc\u00eda","year":"2016","unstructured":"Labandeira-Garc\u00eda JL, Rodriguez-Perez AI, Valenzuela R, Costa-Besada MA, Guerra MJ (2016) Menopause and Parkinson\u2019s disease. Interaction between estrogens and brain renin-angiotensin system in dopaminergic degeneration. Front Neuroendocrinol 43:44\u201359. https:\/\/doi.org\/10.1016\/j.yfrne.2016.09.003","journal-title":"Front Neuroendocrinol"},{"issue":"11","key":"3193_CR14","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/mds.26354","volume":"30","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Kalia SK, Lang AE (2015) Disease-modifying strategies for Parkinson\u2019s disease. Mov Disord 30(11):1442\u20131450. https:\/\/doi.org\/10.1002\/mds.26354","journal-title":"Mov Disord"},{"issue":"1","key":"3193_CR15","first-page":"16","volume":"30","author":"H Vidrio-Morgado","year":"2007","unstructured":"Vidrio-Morgado H, Alonso-Vilatela ME, L\u00f3pez-L\u00f3pez M (2007) Factores gen\u00e9ticos involucrados en la susceptibilidad para desarrollar enfermedad de Parkinson. Salud Ment 30(1):16\u201324","journal-title":"Salud Ment"},{"issue":"6","key":"3193_CR16","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/mds.25502","volume":"28","author":"C Proukakis","year":"2013","unstructured":"Proukakis C, Houlden H, Schapira AH (2013) Somatic alpha-synuclein mutations in Parkinson\u2019s disease: hypothesis and preliminary data. Mov Disord 28(6):705\u2013712. https:\/\/doi.org\/10.1002\/mds.25502","journal-title":"Mov Disord"},{"issue":"1","key":"3193_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3171\/2009.10.FOCUS09220","volume":"28","author":"G Xiromerisiou","year":"2010","unstructured":"Xiromerisiou G, Dardiotis E, Tsimourtou V, Kountra P, Paterakis K, Kapsalaki E, Hadjigeorgiou G (2010) Genetic basis of Parkinson disease. Neurosurg Focus 28(1):17. https:\/\/doi.org\/10.3171\/2009.10.FOCUS09220","journal-title":"Neurosurg Focus"},{"issue":"7","key":"3193_CR18","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1111\/j.1742-4658.2008.06301.x","volume":"275","author":"AC Belin","year":"2008","unstructured":"Belin AC, Westerlund M (2008) Parkinson\u2019s disease: a genetic perspective. FEBS J 275(7):1377\u20131383. https:\/\/doi.org\/10.1111\/j.1742-4658.2008.06301.x","journal-title":"FEBS J"},{"issue":"4","key":"3193_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10048-005-0005-1","volume":"6","author":"I Mata","year":"2005","unstructured":"Mata I, Kachergus J, Taylor J, Lincoln S, Aasly J, Lynch T, Farrer M (2005) Lrrk2 pathogenic substitutions in Parkinson\u2019s disease. Neurogenetics 6(4):171\u2013177. https:\/\/doi.org\/10.1007\/s10048-005-0005-1","journal-title":"Neurogenetics"},{"issue":"17","key":"3193_CR20","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1157\/13087844","volume":"126","author":"A Llad\u00f3","year":"2006","unstructured":"Llad\u00f3 A, Gaig C, Molinuevo JL (2006) Gen\u00e9tica de las enfermedades neurodegenerativas m\u00e1s prevalentes. Med Clin 126(17):662\u2013670. https:\/\/doi.org\/10.1157\/13087844","journal-title":"Med Clin"},{"issue":"4","key":"3193_CR21","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1086\/508025","volume":"79","author":"C Zabetian","year":"2006","unstructured":"Zabetian C, Hutter C, Yearout D, Lopez A, Factor S et al (2006) H LRRK2 G2019S in families with Parkinson disease who originated from Europe and the middle east: evidence of two distinct founding events beginning two millennia ago. Am J Hum Genet 79(4):752\u2013758. https:\/\/doi.org\/10.1086\/508025","journal-title":"Am J Hum Genet"},{"issue":"5290","key":"3193_CR22","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1126\/science.274.5290.1197","volume":"274","author":"MH Polymeropoulos","year":"1996","unstructured":"Polymeropoulos MH, Higgins JJ, Golbe LI, Johnson WG, Ide SE, Di Iorio G et al (1996) Mapping of a gene for Parkinson\u2019s disease to chromosome 4q21-q23. Science 274(5290):1197\u20131199. https:\/\/doi.org\/10.1126\/science.274.5290.1197","journal-title":"Science"},{"issue":"3","key":"3193_CR23","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1212\/wnl.48.3.752","volume":"48","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Hurko O, Hsu F, Rubenstein J, Basnet S et al (1997) Linkage of the locus for cerebral cavernous hemangiomas to human chromosome 7q in four families of Mexican-American descent. Neurology 48(3):752\u2013757. https:\/\/doi.org\/10.1212\/wnl.48.3.752","journal-title":"Neurology"},{"issue":"2","key":"3193_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kr\u00fcger","year":"1998","unstructured":"Kr\u00fcger R, Kuhn W, M\u00fcller T, Woitalla D, Graeber M et al (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat Genet 18(2):106\u2013108. https:\/\/doi.org\/10.1038\/ng0298-106","journal-title":"Nat Genet"},{"issue":"2","key":"3193_CR25","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, G\u00f3mez-Esteban JC, Lezcano E, Ros R et al (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55(2):164\u2013173. https:\/\/doi.org\/10.1002\/ana.10795","journal-title":"Ann Neurol"},{"issue":"3","key":"3193_CR26","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/77060","volume":"25","author":"H Shimura","year":"2000","unstructured":"Shimura H, Hattori N, Si K, Mizuno Y, Asakawa S et al (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 25(3):302\u2013305. https:\/\/doi.org\/10.1038\/77060","journal-title":"Nat Genet"},{"issue":"5","key":"3193_CR27","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1399-0004.2007.00878.x","volume":"72","author":"A Biswas","year":"2007","unstructured":"Biswas A, Maulik M, Das SK, Indian Genome Variation Consortium, Ray K, Ray J (2007) Parkin polymorphisms: risk for Parkinson\u2019s disease in Indian population. Clin Genet. 72(5):484\u2013486. https:\/\/doi.org\/10.1111\/j.1399-0004.2007.00878.x","journal-title":"Clin Genet."},{"issue":"2","key":"3193_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/s0304-3940(00)01733-x","volume":"298","author":"N Pineda-Trujillo","year":"2001","unstructured":"Pineda-Trujillo N, Carvajal-Carmona LG, Buritic\u00e1 O, Moreno S, Uribe C et al (2001) A novel Cys212Tyr founder mutation in parkin and allelic heterogeneity of juvenile Parkinsonism in a population from North West Colombia. Neurosci Lett 298(2):87\u201390. https:\/\/doi.org\/10.1016\/s0304-3940(00)01733-x","journal-title":"Neurosci Lett"},{"issue":"10","key":"3193_CR29","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1097\/00001756-200007140-00004","volume":"11","author":"P Wintermeyer","year":"2000","unstructured":"Wintermeyer P, Kr\u00fcger R, Kuhn W, M\u00fcller T, Woitalla D et al (2000) Mutation analysis and association studies of the UCHL1 gene in German Parkinson\u2019s disease patients. NeuroReport 11(10):2079\u20132082. https:\/\/doi.org\/10.1097\/00001756-200007140-00004","journal-title":"NeuroReport"},{"issue":"7","key":"3193_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0050172","volume":"5","author":"JW Pridgeon","year":"2007","unstructured":"Pridgeon JW, Olzmann JA, Chin LS, Li L (2007) PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol 5(7):e172. https:\/\/doi.org\/10.1371\/journal.pbio.0050172","journal-title":"PLoS Biol"},{"issue":"24","key":"3193_CR31","doi-asserted-by":"publisher","first-page":"9103","DOI":"10.1073\/pnas.0402959101","volume":"101","author":"RM Canet-Avil\u00e9s","year":"2004","unstructured":"Canet-Avil\u00e9s RM, Wilson MA, Miller DW, Ahmad R, McLendon C et al (2004) The Parkinson\u2019s disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci U S A 101(24):9103\u20139108. https:\/\/doi.org\/10.1073\/pnas.0402959101","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3193_CR32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/hmg\/ddl471","volume":"16","author":"AB West","year":"2007","unstructured":"West AB, Moore DJ, Choi C, Andrabi SA, Li X et al (2007) Parkinson\u2019s disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. Hum Mol Genet 16(2):223\u2013232. https:\/\/doi.org\/10.1093\/hmg\/ddl471","journal-title":"Hum Mol Genet"},{"key":"3193_CR33","doi-asserted-by":"publisher","DOI":"10.1515\/reveh-2021-0111","author":"T Chambers-Richards","year":"2021","unstructured":"Chambers-Richards T, Su Y, Chireh B, D\u2019Arcy C (2021) Exposure to toxic occupations and their association with Parkinson\u2019s disease: a systematic review with meta-analysis. Rev Environ Health. https:\/\/doi.org\/10.1515\/reveh-2021-0111","journal-title":"Rev Environ Health"},{"issue":"1","key":"3193_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12940-021-00712-3","volume":"20","author":"BA Racette","year":"2021","unstructured":"Racette BA, Nelson G, Dlamini WW, Prathibha P, Turner JR, Ushe M, Nielsen SS (2021) Severity of parkinsonism associated with environmental manganese exposure. Environ Health 20(1):1\u201313. https:\/\/doi.org\/10.1186\/s12940-021-00712-3","journal-title":"Environ Health"},{"issue":"2","key":"3193_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.17712\/nsj.2020.2.20190104","volume":"25","author":"A Cagac","year":"2020","unstructured":"Cagac A (2020) Farming, well water consumption, rural living, and pesticide exposure in early life as the risk factors for Parkinson disease in I\u011fd\u0131r province. Neurol (Riyadh) 25(2):129\u2013135. https:\/\/doi.org\/10.17712\/nsj.2020.2.20190104","journal-title":"Neurol (Riyadh)"},{"issue":"5","key":"3193_CR36","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s40261-019-00771-y","volume":"39","author":"G Koren","year":"2019","unstructured":"Koren G, Norton G, Radinsky K, Shalev V (2019) Chronic Use of \u03b2-Blockers and the Risk of Parkinson\u2019s Disease. Clin Drug Investig 39(5):463\u2013468. https:\/\/doi.org\/10.1007\/s40261-019-00771-y","journal-title":"Clin Drug Investig"},{"issue":"6","key":"3193_CR37","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ana.23687","volume":"72","author":"AJ Noyce","year":"2012","unstructured":"Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Giovannoni G et al (2012) Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol 72(6):893\u2013901. https:\/\/doi.org\/10.1002\/ana.23687","journal-title":"Ann Neurol"},{"issue":"3","key":"3193_CR38","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s004150050334","volume":"246","author":"G Hageman","year":"1999","unstructured":"Hageman G, van der Hoek J, van Hout M, van der Laan G, Steur EJ, de Bruin W, Herholz K (1999) Parkinsonism, pyramidal signs, polyneuropathy, and cognitive decline after long-term occupational solvent exposure. J Neurol 246(3):198\u2013206. https:\/\/doi.org\/10.1007\/s004150050334","journal-title":"J Neurol"},{"issue":"1","key":"3193_CR39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1017\/s0317167100026147","volume":"14","author":"A Barbeau","year":"1987","unstructured":"Barbeau A, Roy M, Bernier G, Campanella G, Paris S (1987) Ecogenetics of Parkinson\u2019s disease: prevalence and environmental aspects in rural areas. Can J Neurol Sci 14(1):36\u201341. https:\/\/doi.org\/10.1017\/s0317167100026147","journal-title":"Can J Neurol Sci"},{"issue":"6","key":"3193_CR40","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1212\/wnl.43.6.1150","volume":"43","author":"PG Butterfield","year":"1993","unstructured":"Butterfield PG, Valanis BG, Spencer PS, Lindeman CA, Nutt JG (1993) Environmental antecedents of young-onset Parkinson\u2019s disease. Neurology 43(6):1150\u20131158. https:\/\/doi.org\/10.1212\/wnl.43.6.1150","journal-title":"Neurology"},{"issue":"3","key":"3193_CR41","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/ajim.4700170307","volume":"17","author":"C Hertzman","year":"1990","unstructured":"Hertzman C, Wiens M, Bowering D, Snow B, Calne D (1990) Parkinson\u2019s disease: a case-control study of occupational and environmental risk factors. Am J Ind Med 17(3):349\u2013355. https:\/\/doi.org\/10.1002\/ajim.4700170307","journal-title":"Am J Ind Med"},{"issue":"1","key":"3193_CR42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/mds.870090111","volume":"9","author":"C Hertzman","year":"1994","unstructured":"Hertzman C, Wiens M, Snow B, Kelly S, Calne D (1994) A case-control study of Parkinson\u2019s disease in a horticultural region of British Columbia. Mov Disord 9(1):69\u201375. https:\/\/doi.org\/10.1002\/mds.870090111","journal-title":"Mov Disord"},{"issue":"5\u20136","key":"3193_CR43","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/10937404.2019.1659197","volume":"22","author":"C Vaccari","year":"2019","unstructured":"Vaccari C, El Dib R, Gomaa H, Lopes LC, de Camargo JL (2019) Paraquat and Parkinson\u2019s disease: a systematic review and meta-analysis of observational studies. J Toxicol Environ Health B Crit Rev 22(5\u20136):172\u2013202. https:\/\/doi.org\/10.1080\/10937404.2019.1659197","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"3193_CR44","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yrtph.2018.05.005","volume":"96","author":"D Yan","year":"2018","unstructured":"Yan D, Zhang Y, Liu L, Shi N, Yan H (2018) Pesticide exposure and risk of Parkinson\u2019s disease: dose-response meta-analysis of observational studies. Regul Toxicol Pharmacol 96:57\u201363. https:\/\/doi.org\/10.1016\/j.yrtph.2018.05.005","journal-title":"Regul Toxicol Pharmacol"},{"key":"3193_CR45","doi-asserted-by":"publisher","DOI":"10.35371\/aoem.2021.33.e6","volume":"33","author":"Y Kim","year":"2021","unstructured":"Kim Y, Kim I, Sung JM, Song J (2021) Parkinson\u2019s disease in a worker exposed to insecticides at a greenhouse. Ann Occup Environ Med 33:e6. https:\/\/doi.org\/10.35371\/aoem.2021.33.e6","journal-title":"Ann Occup Environ Med"},{"issue":"2","key":"3193_CR46","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.pharmthera.2006.09.002","volume":"113","author":"KM Erikson","year":"2007","unstructured":"Erikson KM, Thompson K, Aschner J, Aschner M (2007) Manganese neurotoxicity: a focus on the neonate. Pharmacol Ther 113(2):369\u2013377. https:\/\/doi.org\/10.1016\/j.pharmthera.2006.09.002","journal-title":"Pharmacol Ther"},{"issue":"4","key":"3193_CR47","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.ncl.2020.08.003","volume":"38","author":"S McKnight","year":"2020","unstructured":"McKnight S, Hack N (2020) Toxin-induced parkinsonism. Neurol Clin 38(4):853\u2013865. https:\/\/doi.org\/10.1016\/j.ncl.2020.08.003","journal-title":"Neurol Clin"},{"key":"3193_CR48","first-page":"227","volume":"20","author":"P Pal","year":"1999","unstructured":"Pal P, Samii A, Calne D (1999) Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicology 20:227\u2013238","journal-title":"Neurotoxicology"},{"key":"3193_CR49","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.neulet.2017.11.054","volume":"665","author":"K Du","year":"2018","unstructured":"Du K, Liu MY, Pan YZ, Zhong X, Wei MJ (2018) Association of circulating manganese levels with Parkinson\u2019s disease: a meta-analysis. Neurosci Lett 665:92\u201398. https:\/\/doi.org\/10.1016\/j.neulet.2017.11.054","journal-title":"Neurosci Lett"},{"issue":"5","key":"3193_CR50","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.neuro.2012.08.012","volume":"33","author":"J Sanchez-Betancourt","year":"2012","unstructured":"Sanchez-Betancourt J, Anaya-Mart\u00ednez V, Guti\u00e9rrez-Valdez A, Ordo\u00f1ez-Librado J, Montiel-Flores E, Espinosa-Villanueva J, \u00c1vila-Costa M (2012) Manganese mixture inhalation is a reliable Parkinson disease model in rats. Neurotoxicology 33(5):1346\u20131355. https:\/\/doi.org\/10.1016\/j.neuro.2012.08.012","journal-title":"Neurotoxicology"},{"key":"3193_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-022-03606-z","author":"QF Zhu","year":"2022","unstructured":"Zhu QF, Lu LL, Fang YY, Wu J, Huang ZY, Zheng XW, Jiang YM (2022) Methylcyclopentadienyl manganese tricarbonyl alter behavior and cause ultrastructural changes in the substantia nigra of rats: comparison with inorganic manganese chloride. Neurochem Res. https:\/\/doi.org\/10.1007\/s11064-022-03606-z","journal-title":"Neurochem Res"},{"issue":"2\u20133","key":"3193_CR52","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.tox.2007.11.018","volume":"244","author":"Y Hirata","year":"2008","unstructured":"Hirata Y, Suzuno H, Tsuruta T, Oh-hashi K, Kiuchi K (2008) The role of dopamine transporter in selective toxicity of manganese and rotenone. Toxicology 244(2\u20133):249\u2013256. https:\/\/doi.org\/10.1016\/j.tox.2007.11.018","journal-title":"Toxicology"},{"issue":"4","key":"3193_CR53","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","volume":"99","author":"JF Cryan","year":"2019","unstructured":"Cryan JF, O\u2019Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS et al (2019) The microbiota-gut-brain axis. Physiol Rev 99(4):1877\u20132013. https:\/\/doi.org\/10.1152\/physrev.00018.2018","journal-title":"Physiol Rev"},{"issue":"5","key":"3193_CR54","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1007\/s00415-012-6801-2","volume":"260","author":"MG Cersosimo","year":"2013","unstructured":"Cersosimo MG, Raina GB, Pecci C, Pellene A, Calandra CR et al (2013) Gastrointestinal manifestations in Parkinson\u2019s disease: prevalence and occurrence before motor symptoms. J Neurol 260(5):1332\u20131338. https:\/\/doi.org\/10.1007\/s00415-012-6801-2","journal-title":"J Neurol"},{"key":"3193_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.636545.V.N","volume":"13","author":"T Shen","year":"2021","unstructured":"Shen T, Yue Y, He T, Huang C, Qu B et al (2021) The association between the gut microbiota and Parkinson\u2019s disease, a meta-analysis. Front Aging Neurosci 13:636545. https:\/\/doi.org\/10.3389\/fnagi.2021.636545.V.N","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"3193_CR56","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1046\/j.1471-4159.1998.70010268.x","volume":"70","author":"E Floor","year":"1998","unstructured":"Floor E, Wetzel MG (1998) Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. J Neurochem 70(1):268\u2013275. https:\/\/doi.org\/10.1046\/j.1471-4159.1998.70010268.x","journal-title":"J Neurochem"},{"issue":"2","key":"3193_CR57","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s11064-011-0619-7","volume":"37","author":"C Venkateshappa","year":"2012","unstructured":"Venkateshappa C, Harish G, Mythri RB, Mahadevan A, Bharath MM et al (2012) Increased oxidative damage and decreased antioxidant function in aging human substantia nigra compared to striatum: implications for Parkinson\u2019s disease. Neurochem Res 37(2):358\u2013369. https:\/\/doi.org\/10.1007\/s11064-011-0619-7","journal-title":"Neurochem Res"},{"issue":"4","key":"3193_CR58","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0922-4106(91)90073-q.S","volume":"208","author":"M Gerlach","year":"1991","unstructured":"Gerlach M, Riederer P, Przuntek H, Youdim MB (1991) MPTP mechanisms of neurotoxicity and their implications for Parkinson\u2019s disease. Euro J Pharmacol 208(4):273\u2013286. https:\/\/doi.org\/10.1016\/0922-4106(91)90073-q.S","journal-title":"Euro J Pharmacol"},{"issue":"51","key":"3193_CR59","doi-asserted-by":"publisher","first-page":"42026","DOI":"10.1074\/jbc.M508628200","volume":"280","author":"A Panov","year":"2005","unstructured":"Panov A, Dikalov S, Shalbuyeva N, Taylor G, Sherer T et al (2005) Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication. J Biol Chem 280(51):42026\u201342035. https:\/\/doi.org\/10.1074\/jbc.M508628200","journal-title":"J Biol Chem"},{"key":"3193_CR60","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/978-3-211-45295-0_68","volume":"70","author":"S Gal","year":"2006","unstructured":"Gal S, Fridkin M, Amit T, Zheng H, Youdim MB (2006) M30, a novel multifunctional neuroprotective drug with potent iron chelating and brain selective monoamine oxidase-ab inhibitory activity for Parkinson\u2019s disease. J Neural Transm Suppl 70:447\u2013456. https:\/\/doi.org\/10.1007\/978-3-211-45295-0_68","journal-title":"J Neural Transm Suppl"},{"issue":"5","key":"3193_CR61","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/jbt.20138","volume":"20","author":"R Soto-Otero","year":"2006","unstructured":"Soto-Otero R, Sanmart\u00edn-Su\u00e1rez C, S\u00e1nchez-Iglesias S, Hermida-Ameijeiras A, S\u00e1nchez-Sellero I, M\u00e9ndez-Alvarez E (2006) Study on the ability of 1,2,3,4-tetrahydropapaveroline to cause oxidative stress: Mechanisms and potential implications in relation to Parkinson\u2019s disease. J Biochem Mol Toxicol 20(5):209\u2013220. https:\/\/doi.org\/10.1002\/jbt.20138","journal-title":"J Biochem Mol Toxicol"},{"key":"3193_CR62","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3389\/fnmol.2018.00467","volume":"11","author":"N Umek","year":"2018","unstructured":"Umek N, Ger\u0161ak B, Vintar N, \u0160o\u0161tari\u010d M, Mavri J (2018) Dopamine autoxidation is controlled by acidic pH. Front Mol Neurosci 11:467. https:\/\/doi.org\/10.3389\/fnmol.2018.00467","journal-title":"Front Mol Neurosci"},{"issue":"7","key":"3193_CR63","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1021\/tx980036t","volume":"11","author":"XM Shen","year":"1998","unstructured":"Shen XM, Dryhurst G (1998) Iron- and manganese-catalyzed autoxidation of dopamine in the presence of L-cysteine: possible insights into iron- and manganese-mediated dopaminergic neurotoxicity. Chem Res Toxicol 11(7):824\u2013837. https:\/\/doi.org\/10.1021\/tx980036t","journal-title":"Chem Res Toxicol"},{"key":"3193_CR64","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-3-7091-0643-3_8","volume":"65","author":"L Zecca","year":"2003","unstructured":"Zecca L, Zucca FA, Costi P, Tampellini D, Gatti A, Gerlach M et al (2003) The neuromelanin of human substantia nigra: structure, synthesis and molecular behaviour. J Neural Transm Suppl 65:145\u2013155. https:\/\/doi.org\/10.1007\/978-3-7091-0643-3_8","journal-title":"J Neural Transm Suppl"},{"issue":"2","key":"3193_CR65","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0168-0102(94)90157-0","volume":"21","author":"D Law-Tho","year":"1994","unstructured":"Law-Tho D, Hirsch JC, Crepel F (1994) Dopamine modulation of synaptic transmission in rat prefrontal cortex: an in vitro electrophysiological study. Neurosci Res 21(2):151\u2013160. https:\/\/doi.org\/10.1016\/0168-0102(94)90157-0","journal-title":"Neurosci Res"},{"issue":"1","key":"3193_CR66","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1046\/j.0022-3042.2001.00684.x","volume":"80","author":"GA Gerhardt","year":"2002","unstructured":"Gerhardt GA, Cass WA, Yi A, Zhang Z, Gash DM (2002) Changes in somatodendritic but not terminal dopamine regulation in aged rhesus monkeys. J Neurochem 80(1):168\u2013177. https:\/\/doi.org\/10.1046\/j.0022-3042.2001.00684.x","journal-title":"J Neurochem"},{"issue":"7886","key":"3193_CR67","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","volume":"599","author":"P Gonz\u00e1lez-Rodr\u00edguez","year":"2021","unstructured":"Gonz\u00e1lez-Rodr\u00edguez P, Zampese E, Stout KA, Guzman JN, Ilijic E et al (2021) Disruption of mitochondrial complex I induces progressive parkinsonism. Nature 599(7886):650\u2013656. https:\/\/doi.org\/10.1038\/s41586-021-04059-0","journal-title":"Nature"},{"issue":"3","key":"3193_CR68","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","volume":"54","author":"AHV Schapira","year":"1990","unstructured":"Schapira AHV, Cooper JM, Dexter D, Clark JB, Jenner P et al (1990) Mitochondrial complex I deficiency in Parkinson\u2019s disease. J Neurochem 54(3):823\u2013827. https:\/\/doi.org\/10.1111\/j.1471-4159.1990.tb02325.x","journal-title":"J Neurochem"},{"issue":"12","key":"3193_CR69","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV et al (2000) Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat Neurosci 3(12):1301\u20131306. https:\/\/doi.org\/10.1038\/81834","journal-title":"Nat Neurosci"},{"issue":"9","key":"3193_CR70","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3390\/cells11091544","volume":"11","author":"RV Z\u00e1rate","year":"2022","unstructured":"Z\u00e1rate RV, Hidalgo S, Navarro N, Molina-Mateo D, Arancibia D et al (2022) An early disturbance in serotonergic neurotransmission contributes to the onset of parkinsonian phenotypes in Drosophila melanogaster. Cells 11(9):1544. https:\/\/doi.org\/10.3390\/cells11091544","journal-title":"Cells"},{"issue":"5","key":"3193_CR71","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/ng1769","volume":"38","author":"A Bender","year":"2006","unstructured":"Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK et al (2006) High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 38(5):515\u2013517. https:\/\/doi.org\/10.1038\/ng1769","journal-title":"Nat Genet"},{"key":"3193_CR72","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/jnc.13266","volume":"139","author":"A Beilina","year":"2016","unstructured":"Beilina A, Cookson MR (2016) Genes associated with Parkinson\u2019s disease: regulation of autophagy and beyond. J Neurochem 139:91\u2013107. https:\/\/doi.org\/10.1111\/jnc.13266","journal-title":"J Neurochem"},{"issue":"12","key":"3193_CR73","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1093\/brain\/awp293","volume":"132","author":"E Hattingen","year":"2009","unstructured":"Hattingen E, Magerkurth J, Pilatus U, Mozer A, Seifried C et al (2009) Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson\u2019s disease. Brain 132(12):3285\u20133297. https:\/\/doi.org\/10.1093\/brain\/awp293","journal-title":"Brain"},{"issue":"3","key":"3193_CR74","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-017-1794-7","volume":"135","author":"IH Fl\u00f8nes","year":"2018","unstructured":"Fl\u00f8nes IH, Fernandez-Vizarra E, Lykouri M, Brakedal B, Skeie GO et al (2018) Neuronal complex I deficiency occurs throughout the Parkinson\u2019s disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage. Acta Neuropathol 135(3):409\u2013425. https:\/\/doi.org\/10.1007\/s00401-017-1794-7","journal-title":"Acta Neuropathol"},{"issue":"2","key":"3193_CR75","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","volume":"21","author":"A Gerhard","year":"2006","unstructured":"Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M et al (2006) In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease. Neurobiol Dis 21(2):404\u2013412. https:\/\/doi.org\/10.1016\/j.nbd.2005.08.002","journal-title":"Neurobiol Dis"},{"issue":"1","key":"3193_CR76","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.parkreldis.2012.07.002","volume":"19","author":"S Iannaccone","year":"2013","unstructured":"Iannaccone S, Cerami C, Alessio M, Garibotto V, Panzacchi A et al (2013) In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson\u2019s disease. Parkinsonism Relat Disord 19(1):47\u201352. https:\/\/doi.org\/10.1016\/j.parkreldis.2012.07.002","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"3193_CR77","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/brain\/awab446","volume":"145","author":"S Smaji\u0107","year":"2022","unstructured":"Smaji\u0107 S, Prada-Medina CA, Landoulsi Z, Ghelfi J, Delcambre S et al (2022) Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state. Brain 145(3):964\u2013978. https:\/\/doi.org\/10.1093\/brain\/awab446","journal-title":"Brain"},{"key":"3193_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2018.12.012","volume":"135","author":"HB Dodiya","year":"2020","unstructured":"Dodiya HB, Forsyth CB, Voigt RM, Engen PA, Patel J et al (2020) Chronic stress-induced gut dysfunction exacerbates Parkinson\u2019s disease phenotype and pathology in a rotenone-induced mouse model of Parkinson\u2019s disease. Neurobiol Dis 135:104352. https:\/\/doi.org\/10.1016\/j.nbd.2018.12.012","journal-title":"Neurobiol Dis"},{"issue":"6","key":"3193_CR79","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang W, Wang T, Pei Z, Miller DS, Wu X et al (2005) Aggregated \u03b1-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease. FASEB J 19(6):533\u2013542. https:\/\/doi.org\/10.1096\/fj.04-2751com","journal-title":"FASEB J"},{"issue":"2","key":"3193_CR80","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.neulet.2008.06.040","volume":"441","author":"B Brodacki","year":"2008","unstructured":"Brodacki B, Staszewski J, Toczy\u0142owska B, Koz\u0142owska E, Drela N et al (2008) Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNF\u03b1, and INF\u03b3 concentrations are elevated in patients with atypical and idiopathic parkinsonism. Neurosci Lett 441(2):158\u2013162. https:\/\/doi.org\/10.1016\/j.neulet.2008.06.040","journal-title":"Neurosci Lett"},{"key":"3193_CR81","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3389\/fneur.2018.01081","volume":"9","author":"JB Schr\u00f6der","year":"2018","unstructured":"Schr\u00f6der JB, Pawlowski M, Meyer zu H\u00f6rste G, Gross CC, Wiendl H et al (2018) Immune cell activation in the cerebrospinal fluid of patients with Parkinson\u2019s disease. Front Neurol 9:1081. https:\/\/doi.org\/10.3389\/fneur.2018.01081","journal-title":"Front Neurol"},{"issue":"1\u20132","key":"3193_CR82","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0304-3940(94)90684-x","volume":"172","author":"G Boka","year":"1994","unstructured":"Boka G, Anglade P, Wallach D, Javoy-Agid F, Agid Y, Hirsch EC (1994) Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson\u2019s disease. Neurosci Lett 172(1\u20132):151\u2013154. https:\/\/doi.org\/10.1016\/0304-3940(94)90684-x","journal-title":"Neurosci Lett"},{"issue":"3","key":"3193_CR83","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s007020050028","volume":"107","author":"M Mogi","year":"2000","unstructured":"Mogi M, Togari A, Kondo T, Mizuno Y, Komure O et al (2000) Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from parkinsonian brain. J Neural Transm (Vienna) 107(3):335\u2013341. https:\/\/doi.org\/10.1007\/s007020050028","journal-title":"J Neural Transm (Vienna)"},{"issue":"3","key":"3193_CR84","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/s0304-3940(00)01701-8","volume":"297","author":"KSP McNaught","year":"2001","unstructured":"McNaught KSP, Jenner P (2001) Proteasomal function is impaired in substantia nigra in Parkinson\u2019s disease. Neurosci Lett 297(3):191\u2013194. https:\/\/doi.org\/10.1016\/s0304-3940(00)01701-8","journal-title":"Neurosci Lett"},{"issue":"1","key":"3193_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-019-0533-9","volume":"11","author":"S Sj\u00f6din","year":"2019","unstructured":"Sj\u00f6din S, Brinkmalm G, \u00d6hrfelt A, Parnetti L, Paciotti S et al (2019) Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer\u2019s and Parkinson\u2019s disease. Alzheimers Res Ther 11(1):1\u201316. https:\/\/doi.org\/10.1186\/s13195-019-0533-9","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"3193_CR86","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025817","volume":"9","author":"K Barlan","year":"2017","unstructured":"Barlan K, Gelfand VI (2017) Microtubule-based transport and the distribution, tethering, and organization of organelles. Cold Spring Harb Perspect Biol 9(5):a025817. https:\/\/doi.org\/10.1101\/cshperspect.a025817","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3193_CR87","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fncom.2013.00013","volume":"7","author":"EK Pissadaki","year":"2013","unstructured":"Pissadaki EK, Bolam JP (2013) The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson\u2019s disease. Front Comput Neurosci 7:13. https:\/\/doi.org\/10.3389\/fncom.2013.00013","journal-title":"Front Comput Neurosci"},{"issue":"3","key":"3193_CR88","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tins.2014.12.009Hunnetal.,2015","volume":"38","author":"BH Hunn","year":"2015","unstructured":"Hunn BH, Cragg SJ, Bolam JP, Spillantini MG, Wade-Martins R (2015) Impaired intracellular trafficking defines early Parkinson\u2019s disease. Trends Neurosci 38(3):178\u2013188. https:\/\/doi.org\/10.1016\/j.tins.2014.12.009Hunnetal.,2015","journal-title":"Trends Neurosci"},{"issue":"8","key":"3193_CR89","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1523\/JNEUROSCI.23-08-03316.2003","volume":"23","author":"Y Ren","year":"2003","unstructured":"Ren Y, Zhao J, Feng J (2003) Parkin binds to alpha\/beta tubulin and increases their ubiquitination and degradation. J Neurosci 23(8):3316\u20133324. https:\/\/doi.org\/10.1523\/JNEUROSCI.23-08-03316.2003","journal-title":"J Neurosci"},{"issue":"3","key":"3193_CR90","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1128\/mcb.9.3.1049-1059.1989","volume":"9","author":"D Burke","year":"1989","unstructured":"Burke D, Gasdaska P, Hartwell L (1989) Dominant effects of tubulin overexpression in Saccharomyces cerevisiae. Mol Cell Biol 9(3):1049\u20131059. https:\/\/doi.org\/10.1128\/mcb.9.3.1049-1059.1989","journal-title":"Mol Cell Biol"},{"issue":"17","key":"3193_CR91","doi-asserted-by":"publisher","first-page":"17154","DOI":"10.1074\/jbc.M500843200","volume":"280","author":"F Yang","year":"2005","unstructured":"Yang F, Jiang Q, Zhao J, Ren Y, Sutton MD, Feng J (2005) Parkin stabilizes microtubules through strong binding mediated by three independent domains. J Biol Chem 280(17):17154\u201317162. https:\/\/doi.org\/10.1074\/jbc.M500843200","journal-title":"J Biol Chem"},{"issue":"1","key":"3193_CR92","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/stem.Renetal.,2015)","volume":"33","author":"Y Ren","year":"2015","unstructured":"Ren Y, Jiang H, Hu Z, Fan K et al (2015) Parkin mutations reduce the complexity of neuronal processes in iPSC-derived human neurons. Stem Cells 33(1):68\u201378. https:\/\/doi.org\/10.1002\/stem.Renetal.,2015","journal-title":"Stem Cells"},{"issue":"16","key":"3193_CR93","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1016\/j.yexcr.2007.07.007.Guoetal.,2007","volume":"313","author":"L Guo","year":"2007","unstructured":"Guo L, Gandhi PN et al (2007) The Parkinson\u2019s disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity. Exp Cell Res 313(16):3658\u20133670. https:\/\/doi.org\/10.1016\/j.yexcr.2007.07.007.Guoetal.,2007","journal-title":"Exp Cell Res"},{"issue":"4","key":"3193_CR94","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.neuron.2006.10.008","volume":"52","author":"D MacLeod","year":"2006","unstructured":"MacLeod D, Dowman J, Hammond R, Leete T, Inoue K, Abeliovich A (2006) The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 52(4):587\u2013593. https:\/\/doi.org\/10.1016\/j.neuron.2006.10.008","journal-title":"Neuron"},{"key":"3193_CR95","doi-asserted-by":"publisher","first-page":"5245","DOI":"10.1038\/ncomms6245","volume":"5","author":"VK Godena","year":"2014","unstructured":"Godena VK, Brookes-Hocking N, Moller A, Shaw G, Oswald M et al (2014) Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations. Nat Commun 5:5245. https:\/\/doi.org\/10.1038\/ncomms6245","journal-title":"Nat Commun"},{"key":"3193_CR96","doi-asserted-by":"publisher","unstructured":"Schwab AJ, Ebert AD (2015) Neurite aggregation and calcium dysfunction in iPSC-derived sensory neurons with Parkinson\u2019s disease-related LRRK2 G2019S mutation. Stem Cell Reports 5(6):1039\u20131052. https:\/\/doi.org\/10.1016\/j.stemcr.2015.11.004.Schwabetal.,2015","DOI":"10.1016\/j.stemcr.2015.11.004.Schwabetal.,2015"},{"issue":"18","key":"3193_CR97","doi-asserted-by":"publisher","first-page":"5783","DOI":"10.1021\/bi052151q","volume":"45","author":"J Madine","year":"2006","unstructured":"Madine J, Doig AJ, Middleton DA (2006) A study of the regional effects of alpha-synuclein on the organization and stability of phospholipid bilayers. Biochemistry, 9 45(18):5783\u20135792. https:\/\/doi.org\/10.1021\/bi052151q","journal-title":"Biochemistry, 9"},{"issue":"7","key":"3193_CR98","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1007\/s11033-009-9899-2","volume":"37","author":"RM Zhou","year":"2010","unstructured":"Zhou RM, Huang YX, Li XL, Chen C, Shi Q et al (2010) (2010) Molecular interaction of \u03b1-synuclein with tubulin influences on the polymerization of microtubule in vitro and structure of microtubule in cells. Mol Biol Rep 37(7):3183\u20133192. https:\/\/doi.org\/10.1007\/s11033-009-9899-2","journal-title":"Mol Biol Rep"},{"issue":"3","key":"3193_CR99","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1074\/jbc.M102981200","volume":"277","author":"MA Alim","year":"2002","unstructured":"Alim MA, Hossain MS, Arima K et al (2002) Tubulin seeds alpha-synuclein fibril formation. J Biol Chem 277(3):2112\u20132117","journal-title":"J Biol Chem"},{"issue":"30","key":"3193_CR100","doi-asserted-by":"publisher","first-page":"21742","DOI":"10.1074\/jbc.M113.451815","volume":"288","author":"I Prots","year":"2013","unstructured":"Prots I, Veber V, Brey S, Campioni S, Buder K, Riek R, B\u00f6hm KJ, Winner B (2013) \u03b1-Synuclein oligomers impair neuronal microtubule-kinesin interplay. J Biol Chem 288(30):21742\u201321754. https:\/\/doi.org\/10.1074\/jbc.M113.451815","journal-title":"J Biol Chem"},{"key":"3193_CR101","doi-asserted-by":"publisher","first-page":"33289","DOI":"10.1038\/srep33289","volume":"6","author":"D Cartelli","year":"2016","unstructured":"Cartelli D, Aliverti A, Barbiroli A et al (2016) \u03b1-Synuclein is a novel microtubule dynamase. Sci Rep 6:33289. https:\/\/doi.org\/10.1038\/srep33289","journal-title":"Sci Rep"},{"issue":"3","key":"3193_CR102","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1089\/ars.2008.2247","volume":"11","author":"AR Esteves","year":"2009","unstructured":"Esteves AR, Ardu\u00edno DM, Swerdlow RH, Oliveira CR, Cardoso SM (2009) Oxidative stress involvement in alpha-synuclein oligomerization in Parkinson\u2019s disease cybrids. Antioxid Redox Signal 11(3):439\u2013448. https:\/\/doi.org\/10.1089\/ars.2008.2247","journal-title":"Antioxid Redox Signal"},{"key":"3193_CR103","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1038\/srep01837","volume":"3","author":"D Cartelli","year":"2013","unstructured":"Cartelli D, Casagrande F, Busceti CL, Bucci D, Molinaro G, Traficante A, Passarella D, Giavini E et al (2013) Microtubule alterations occur early in experimental parkinsonism and the microtubule stabilizer epothilone D is neuroprotective. Sci Rep 3:1837. https:\/\/doi.org\/10.1038\/srep01837","journal-title":"Sci Rep"},{"issue":"7","key":"3193_CR104","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.3390\/ijms21072464","volume":"21","author":"SJ Chia","year":"2020","unstructured":"Chia SJ, Tan EK, Chao YX (2020) Historical perspective: models of Parkinson\u2019s disease. Int J Mol Sci 21(7):2464. https:\/\/doi.org\/10.3390\/ijms21072464","journal-title":"Int J Mol Sci"},{"key":"3193_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpc.2021.109213","volume":"252","author":"T Thirugnanam","year":"2022","unstructured":"Thirugnanam T, Santhakumar K (2022) Chemically induced models of Parkinson\u2019s disease. Comp Biochem Physiol C Toxicol Pharmacol 252:109213. https:\/\/doi.org\/10.1016\/j.cbpc.2021.109213","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"issue":"s1","key":"3193_CR106","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.3233\/JPD-179006","volume":"7","author":"JW Langston","year":"2017","unstructured":"Langston JW (2017) The MPTP story. J Parkinsons Dis 7(s1):S11\u2013S19. https:\/\/doi.org\/10.3233\/JPD-179006","journal-title":"J Parkinsons Dis"},{"issue":"4","key":"3193_CR107","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1023\/B:JOBB.0000041771.66775.d5","volume":"36","author":"S Przedborski","year":"2004","unstructured":"Przedborski S, Tieu K, Perier C, Vila M (2004) MPTP as a mitochondrial neurotoxic model of Parkinson\u2019s disease. J Bioenerg Biomembr 36(4):375\u2013379. https:\/\/doi.org\/10.1023\/B:JOBB.0000041771.66775.d5","journal-title":"J Bioenerg Biomembr"},{"issue":"5","key":"3193_CR108","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","volume":"76","author":"S Przedborski","year":"2001","unstructured":"Przedborski S, Jackson-Lewis V, Naini AB, Jakowec M, Petzinger G, Miller R, Akram M (2001) The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J Neurochem 76(5):1265\u20131274. https:\/\/doi.org\/10.1046\/j.1471-4159.2001.00183.x","journal-title":"J Neurochem"},{"issue":"2","key":"3193_CR109","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1748-1716.1986.tb07965.x","volume":"128","author":"G Jonsson","year":"1986","unstructured":"Jonsson G, Nwanze E, Luthman J, Sundstr\u00f6m E (1986) Effect of MPTP and its pyridinium metabolites on monoamine uptake and on central catecholamine neurons in mice. Acta Physiol Scand 128(2):187\u2013194. https:\/\/doi.org\/10.1111\/j.1748-1716.1986.tb07965.x","journal-title":"Acta Physiol Scand"},{"issue":"6","key":"3193_CR110","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/s0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39(6):889\u2013909. https:\/\/doi.org\/10.1016\/s0896-6273(03)00568-3","journal-title":"Neuron"},{"issue":"23","key":"3193_CR111","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1016\/0024-3205(88)90189-0","volume":"42","author":"NJ Riachi","year":"1988","unstructured":"Riachi NJ, Harik SI (1988) Strain differences in systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice correlate best with monoamine oxidase activity at the blood-brain barrier. Life Sci 42(23):2359\u20132363. https:\/\/doi.org\/10.1016\/0024-3205(88)90189-0","journal-title":"Life Sci"},{"issue":"3","key":"3193_CR112","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0014-2999(85)90304-8","volume":"119","author":"HH Keller","year":"1985","unstructured":"Keller HH, Da Prada M (1985) Evidence for the release of 1-methyl-4-phenylpyridinium (MPP+) from rat striatal neurons in vitro. Eur J Pharmacol 119(3):247\u2013250. https:\/\/doi.org\/10.1016\/0014-2999(85)90304-8","journal-title":"Eur J Pharmacol"},{"key":"3193_CR113","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fnana.2014.00155","volume":"8","author":"J Blesa","year":"2014","unstructured":"Blesa J, Przedborski S (2014) Parkinson\u2019s disease: animal models and dopaminergic cell vulnerability. Front Neuroanat 8:155. https:\/\/doi.org\/10.3389\/fnana.2014.00155","journal-title":"Front Neuroanat"},{"issue":"9","key":"3193_CR114","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1073\/pnas.0409713102","volume":"102","author":"F Fornai","year":"2005","unstructured":"Fornai F, Schl\u00fcter OM, Lenzi P, Gesi M, Ruffoli R, Ferrucci M et al (2005) Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci U S A 102(9):3413\u20133418. https:\/\/doi.org\/10.1073\/pnas.0409713102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3193_CR115","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3892\/mmr.2022.12607","volume":"25","author":"J Zhang","year":"2022","unstructured":"Zhang J, Sun B, Yang J, Chen Z, Li Z et al (2022) Comparison of the effect of rotenone and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on inducing chronic Parkinson\u2019s disease in mouse models. Mol Med Rep 25(3):91. https:\/\/doi.org\/10.3892\/mmr.2022.12607. (Epub 2022 Jan 18)","journal-title":"Mol Med Rep"},{"key":"3193_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.107900)","volume":"164","author":"RM Salama","year":"2020","unstructured":"Salama RM, Abdel-Latif GA, Abbas SS, El Magdoub HM, Schaalan MF (2020) Neuroprotective effect of crocin against rotenone-induced Parkinson\u2019s disease in rats: Interplay between PI3K\/Akt\/mTOR signaling pathway and enhanced expression of miRNA-7 and miRNA-221. Neuropharmacology 164:107900. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107900)","journal-title":"Neuropharmacology"},{"issue":"5","key":"3193_CR117","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s43440-020-00095-1","volume":"72","author":"G Ozbey","year":"2020","unstructured":"Ozbey G, Nemutlu-Samur D, Parlak H, Yildirim S, Aslan M, Tanriover G, Agar A (2020) Metformin protects rotenone-induced dopaminergic neurodegeneration by reducing lipid peroxidation. Pharmacol Rep 72(5):1397\u20131406. https:\/\/doi.org\/10.1007\/s43440-020-00095-1","journal-title":"Pharmacol Rep"},{"key":"3193_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.810148","volume":"16","author":"LJ Bigelow","year":"2022","unstructured":"Bigelow LJ, Perry MA, Ogilvie SL, Tasker RA (2022) Longitudinal assessment of behaviour and associated bio-markers following chronic consumption of \u03b2-Sitosterol \u03b2-D-Glucoside in rats: a putative model of Parkinson\u2019s disease. Front Neurosci 16:810148. https:\/\/doi.org\/10.3389\/fnins.2022.810148","journal-title":"Front Neurosci"},{"issue":"2","key":"3193_CR119","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1021\/cr60042a001","volume":"12","author":"FB La Forge","year":"1993","unstructured":"La Forge FB, Haller HL, Smith LE (1993) The determination of the structure of rotenone. Chem Rev 12(2):181\u2013213","journal-title":"Chem Rev"},{"key":"3193_CR120","unstructured":"Bettoli PW, Maceina MJ (1996) Sampling with toxicants. In: Murphy, B.R., Willis, D.R. (Eds) Fisheries Techniques. 2nd edition. American Fisheries Society, Bethesda, MD"},{"key":"3193_CR121","first-page":"1","volume":"211","author":"N Ling","year":"2003","unstructured":"Ling N (2003) Rotenone\u00f4a review of its toxicity and use for fisheries management. Sci Conserv 211:1\u201340","journal-title":"Sci Conserv"},{"issue":"5","key":"3193_CR122","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1021\/jf981188x","volume":"47","author":"N Fang","year":"1999","unstructured":"Fang N, Casida JE (1999) Cube resin insecticide: identification and biological activity of 29 rotenoid constituents. J Agri Food Chem 47(5):2130\u20132136. https:\/\/doi.org\/10.1021\/jf981188x","journal-title":"J Agri Food Chem"},{"issue":"1","key":"3193_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.17711\/SM.0185-3325.2013.001","volume":"36","author":"M G\u00f3mez-Chavar\u00edn","year":"2013","unstructured":"G\u00f3mez-Chavar\u00edn M, D\u00edaz-P\u00e9rez R, Morales-Espinosa R, Fern\u00e1ndez-Ruiz J, Rold\u00e1n-Rold\u00e1n G, Torner C (2013) Efecto de la exposici\u00f3n al pesticida rotenona sobre el desarrollo del sistema dopamin\u00e9rgico nigro-estriatal en ratas. Salud Ment 36(1):1\u20138","journal-title":"Salud Ment"},{"key":"3193_CR124","unstructured":"World Health Organization, 2020. The WHO recommended classification of pesticides by hazard and guidelines to classification, 2019 edition. Recovered from: https:\/\/www.who.int\/publications\/i\/item\/9789240005662. WHO 92:37"},{"key":"3193_CR125","doi-asserted-by":"publisher","unstructured":"Innos J and Hickey MA (2021) Using rotenone to model Parkinson\u2019s disease in mice: a review of the role of pharmacokinetics. Chem Res Toxicol 34(5):1223\u20131239.\u00a0https:\/\/doi.org\/10.1021\/acs.chemrestox.0c00522","DOI":"10.1021\/acs.chemrestox.0c00522"},{"issue":"7","key":"3193_CR126","first-page":"984","volume":"88","author":"P Narongchai","year":"2005","unstructured":"Narongchai P, Narongchai S, Thampituk S (2005) The first fatal case of yam bean and rotenone toxicity in Thailand. J Med Assoc Thai 88(7):984\u2013987","journal-title":"J Med Assoc Thai"},{"issue":"2","key":"3193_CR127","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0035-9203(38)90078-1","volume":"32","author":"EA Holland","year":"1938","unstructured":"Holland EA (1938) Suicide by Ingestion of Derris Root Sp. in New Ireland. Trans Royal Soc Trop Med Hygiene 32(2):293\u2013294","journal-title":"Trans Royal Soc Trop Med Hygiene"},{"issue":"4","key":"3193_CR128","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1520\/JFS11931J","volume":"31","author":"AR De Wilde","year":"1986","unstructured":"De Wilde AR, Heyndrickx A, Carton D (1986) A case of fatal rotenone poisoning in a child. J Forensic Sci 31(4):1492\u20131498","journal-title":"J Forensic Sci"},{"issue":"3","key":"3193_CR129","doi-asserted-by":"publisher","first-page":"R280","DOI":"10.1186\/cc3528","volume":"9","author":"DM Wood","year":"2005","unstructured":"Wood DM, Alsahaf H, Streete P, Dargan PI, Jones AL (2005) Fatality after deliberate ingestion of the pesticide rotenone: a case report. Crit Care 9(3):R280-284. https:\/\/doi.org\/10.1186\/cc3528","journal-title":"Crit Care"},{"issue":"1","key":"3193_CR130","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/10599240801986215","volume":"13","author":"AS Dhillon","year":"2008","unstructured":"Dhillon AS, Tarbutton GL, Levin JL, Plotkin GM, Lowry LK et al (2008) Pesticide\/environmental exposures and Parkinson\u2019s disease in East Texas. J Agromedicine 13(1):37\u201348. https:\/\/doi.org\/10.1080\/10599240801986215","journal-title":"J Agromedicine"},{"issue":"3","key":"3193_CR131","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0304-3940(85)90580-4","volume":"62","author":"RE Heikkila","year":"1985","unstructured":"Heikkila RE, Nicklas WJ, Vyas I, Duvoisin RC (1985) Duvoisin, Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine toxicity. Neurosci Lett. 62(3):389\u2013394. https:\/\/doi.org\/10.1016\/0304-3940(85)90580-4","journal-title":"Neurosci Lett."},{"key":"3193_CR132","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s0006-8993(97)00008-5","volume":"753","author":"RJ Ferrante","year":"1997","unstructured":"Ferrante RJ, Schulz JB, Kowall NW, Beal MF (1997) Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra. Brain Res 753:157\u2013162. https:\/\/doi.org\/10.1016\/s0006-8993(97)00008-5","journal-title":"Brain Res"},{"issue":"2","key":"3193_CR133","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.expneurol.2003.12.005","volume":"186","author":"V Bashkatova","year":"2004","unstructured":"Bashkatova V, Alam M, Vanin A, Schmidt WJ (2004) Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain. Exp Neurol 186(2):235\u2013241. https:\/\/doi.org\/10.1016\/j.expneurol.2003.12.005","journal-title":"Exp Neurol"},{"issue":"2","key":"3193_CR134","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.expneurol.2004.01.023","volume":"187","author":"SM Fleming","year":"2004","unstructured":"Fleming SM, Zhu C, Fernagut PO, Mehta A, DiCarlo CD et al (2004) Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone. Exp Neurol 187(2):418\u2013429. https:\/\/doi.org\/10.1016\/j.expneurol.2004.01.023","journal-title":"Exp Neurol"},{"issue":"2","key":"3193_CR135","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/s0006-8993(00)02960-7","volume":"885","author":"C Thiffault","year":"2000","unstructured":"Thiffault C, Langston JW, Di Monte DA (2000) Increased striatal dopamine turnover following acute administration of rotenone to mice. Brain Res 885(2):283\u2013288. https:\/\/doi.org\/10.1016\/s0006-8993(00)02960-7","journal-title":"Brain Res"},{"issue":"1","key":"3193_CR136","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0166-4328(02)00180-8","volume":"136","author":"M Alam","year":"2002","unstructured":"Alam M, Schmidt WJ (2002) Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav Brain Res 136(1):317\u2013324","journal-title":"Behav Brain Res"},{"issue":"2","key":"3193_CR137","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","volume":"34","author":"JR Cannon","year":"2009","unstructured":"Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE et al (2009) A highly reproducible rotenone model of Parkinson\u2019s disease. Neurobiol Dis 34(2):279\u2013290. https:\/\/doi.org\/10.1016\/j.nbd.2009.01.016","journal-title":"Neurobiol Dis"},{"issue":"48","key":"3193_CR138","doi-asserted-by":"publisher","first-page":"10993","DOI":"10.1523\/JNEUROSCI.2993-04.2004","volume":"24","author":"H Coulom","year":"2004","unstructured":"Coulom H, Birman S (2004) Chronic exposure to rotenone models sporadic Parkinson\u2019s disease in Drosophila melanogaster. J Neurosci 24(48):10993\u201310998. https:\/\/doi.org\/10.1523\/JNEUROSCI.2993-04.2004","journal-title":"J Neurosci"},{"issue":"8","key":"3193_CR139","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.neuropharm.2008.08.033","volume":"55","author":"AA Abdin","year":"2008","unstructured":"Abdin AA, Hamouda HE (2008) Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism. Neuropharmacology 55(8):1340\u20131346. https:\/\/doi.org\/10.1016\/j.neuropharm.2008.08.033","journal-title":"Neuropharmacology"},{"key":"3193_CR140","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neuint.2018.10.015","volume":"121","author":"N Serrano-Garc\u00eda","year":"2018","unstructured":"Serrano-Garc\u00eda N, Fern\u00e1ndez-Valverde F, Luis-Garcia ER, Granados-Rojas L, Ju\u00e1rez-Zepeda TE et al (2018) Docosahexaenoic acid protection in a rotenone induced Parkinson\u2019s model: prevention of tubulin and synaptophysin loss, but no association with mitochondrial function. Neurochem Int 121:26\u201337. https:\/\/doi.org\/10.1016\/j.neuint.2018.10.015","journal-title":"Neurochem Int"},{"issue":"11","key":"3193_CR141","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258928","volume":"16","author":"S Madiha","year":"2021","unstructured":"Madiha S, Batool Z, Tabassum S, Liaquat L, Sadir S et al (2021) Quercetin exhibits potent antioxidant activity, restores motor and non-motor deficits induced by rotenone toxicity. PLoS ONE 16(11):e0258928. https:\/\/doi.org\/10.1371\/journal.pone.0258928","journal-title":"PLoS ONE"},{"issue":"2","key":"3193_CR142","doi-asserted-by":"publisher","first-page":"127","DOI":"10.5603\/FHC.a2020.0011","volume":"58","author":"S Chen","year":"2020","unstructured":"Chen S, Xiao Z, Wu H, Zhou G, Xu C et al (2020) Bisdemethoxycurcumin exerts a cell-protective effect via JAK2\/STAT3 signaling in a rotenone-induced Parkinson\u2019s disease model in vitro. Folia Histochem Cytobiol 58(2):127\u2013134. https:\/\/doi.org\/10.5603\/FHC.a2020.0011","journal-title":"Folia Histochem Cytobiol"},{"key":"3193_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2022.106225","volume":"147","author":"BN Palanisamy","year":"2022","unstructured":"Palanisamy BN, Sarkar S, Malovic E, Samidurai M, Charli A et al (2022) Environmental neurotoxic pesticide exposure induces gut inflammation and enteric neuronal degeneration by impairing enteric glial mitochondrial function in pesticide models of Parkinson\u2019s Disease: potential relevance to gut-brain axis inflammation in Parkinson\u2019s disease pathogenesis. Int J Biochem Cell Biol 147:106225. https:\/\/doi.org\/10.1016\/j.biocel.2022.106225","journal-title":"Int J Biochem Cell Biol"},{"issue":"9423","key":"3193_CR144","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","volume":"363","author":"A Samii","year":"2004","unstructured":"Samii A, Nutt JG, Ransom BR (2004) Parkinson\u2019s disease. Lancet 363(9423):1783\u20131793. https:\/\/doi.org\/10.1016\/S0140-6736(04)16305-8","journal-title":"Lancet"},{"issue":"6","key":"3193_CR145","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s12272-022-01386-2","volume":"45","author":"SH Moon","year":"2022","unstructured":"Moon SH, Kwon Y, Huh YE, Choi HJ (2022) Trehalose ameliorates prodromal non-motor deficits and aberrant protein accumulation in a rotenone-induced mouse model of Parkinson\u2019s disease. Arch Pharm Res 45(6):417\u2013432. https:\/\/doi.org\/10.1007\/s12272-022-01386-2","journal-title":"Arch Pharm Res"},{"key":"3193_CR146","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.neuro.2016.11.006","volume":"58","author":"Y Wang","year":"2017","unstructured":"Wang Y, Liu W, Yang J, Wang F, Sima Y et al (2017) Parkinson\u2019s disease-like motor and non-motor symptoms in rotenone-treated zebrafish. Neurotoxicology 58:103\u2013109. https:\/\/doi.org\/10.1016\/j.neuro.2016.11.006","journal-title":"Neurotoxicology"},{"issue":"1","key":"3193_CR147","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12974-020-02065-z","volume":"18","author":"D Zhang","year":"2021","unstructured":"Zhang D, Li S, Hou L, Jing L, Ruan Z et al (2021) Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson\u2019s disease model. J Neuroinflammation 18(1):4. https:\/\/doi.org\/10.1186\/s12974-020-02065-z","journal-title":"J Neuroinflammation"},{"key":"3193_CR148","doi-asserted-by":"publisher","unstructured":"Adebayo OG, Asiwe JN, Ben\u2010Azu B, Aduema W, Onyeleonu I, et al (2020) Ginkgo biloba protects striatal neurodegeneration and gut phagoinflammatory damage in rotenone\u2010induced mice model of Parkinson\u2019s disease: role of executioner caspase\u20103\/Nrf2\/ARE signaling. J Food Biochem e14253. https:\/\/doi.org\/10.1111\/jfbc.14253","DOI":"10.1111\/jfbc.14253"},{"issue":"1","key":"3193_CR149","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41422-019-0241-9","volume":"30","author":"EH Ahn","year":"2020","unstructured":"Ahn EH, Kang SS, Liu X, Chen G, Zhang Z et al (2020) Initiation of Parkinson\u2019s disease from gut to brain by \u03b4-secretase. Cell Res 30(1):70\u201387. https:\/\/doi.org\/10.1038\/s41422-019-0241-9","journal-title":"Cell Res"},{"key":"3193_CR150","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1046\/j.1471-4159.2003.01533.x","volume":"84","author":"GU H\u00f6glinger","year":"2003","unstructured":"H\u00f6glinger GU, Feger J, Prigent A, Michel P, Parain K et al (2003) Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J Neurochem 84:491\u2013502. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.01533.x","journal-title":"J Neurochem"},{"key":"3193_CR151","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.018","volume":"62","author":"YT Sui","year":"2014","unstructured":"Sui YT, Bullock KM, Erickson MA, Zhang J, Banks WA (2014) alpha-synuclein is transported into and out of the brain by the blood\u2013brain barrier. Peptides 62:197\u2013202. https:\/\/doi.org\/10.1016\/j.peptides.2014.09.018","journal-title":"Peptides"},{"key":"3193_CR152","doi-asserted-by":"publisher","unstructured":"George JM (2002) The synucleins. Genome Biol. 3(1):REVIEWS3002. https:\/\/doi.org\/10.1186\/gb-2001-3-1-reviews3002","DOI":"10.1186\/gb-2001-3-1-reviews3002"},{"key":"3193_CR153","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4103\/1735-1995.181989","volume":"21","author":"FN Emamzadeh","year":"2016","unstructured":"Emamzadeh FN (2016) alpha-synuclein structure, functions, and interactions. J Res Med Sci 21:29. https:\/\/doi.org\/10.4103\/1735-1995.181989","journal-title":"J Res Med Sci"},{"issue":"5\u20136","key":"3193_CR154","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00775-016-1376-5","volume":"21","author":"EE Rodr\u00edguez","year":"2016","unstructured":"Rodr\u00edguez EE, Arcos-L\u00f3pez T, Trujano-Ortiz LG, Fern\u00e1ndez CO, Gonz\u00e1lez FJ et al (2016) Role of N-terminal methionine residues in the redox activity of copper bound to apha-synuclein. J Biol Inorg Chem 21(5\u20136):691\u2013702. https:\/\/doi.org\/10.1007\/s00775-016-1376-5","journal-title":"J Biol Inorg Chem"},{"issue":"2","key":"3193_CR155","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0896-6273(95)90040-3","volume":"15","author":"JM George","year":"1995","unstructured":"George JM, Jin H, Woods WS, Clayton DF (1995) Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15(2):361\u2013372. https:\/\/doi.org\/10.1016\/0896-6273(95)90040-3","journal-title":"Neuron"},{"key":"3193_CR156","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0079-6123(10)83007-9","volume":"183","author":"A Oueslati","year":"2010","unstructured":"Oueslati A, Fournier M, Lashuel HA (2010) Role of post-translational modifications in modulating the structure, function and toxicity of \u03b1-synuclein: implications for Parkinson\u2019s disease pathogenesis and therapies. Prog Brain Res 183:115\u2013145. https:\/\/doi.org\/10.1016\/S0079-6123(10)83007-9","journal-title":"Prog Brain Res"},{"issue":"2","key":"3193_CR157","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E et al (2002) \u03b1-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4(2):60\u2013164. https:\/\/doi.org\/10.1038\/ncb748","journal-title":"Nat Cell Biol"},{"issue":"1","key":"3193_CR158","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.bbrc.2007.04.108","volume":"358","author":"M Nakai","year":"2007","unstructured":"Nakai M, Fujita M, Waragai M, Sugama S, Wei J et al (2007) Expression of \u03b1-synuclein, a presynaptic protein implicated in Parkinson\u2019s disease, in erythropoietic lineage. Biochem Biophys Res Commun 358(1):104\u2013110. https:\/\/doi.org\/10.1016\/j.bbrc.2007.04.108","journal-title":"Biochem Biophys Res Commun"},{"issue":"7362","key":"3193_CR159","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature10324","volume":"477","author":"T Bartels","year":"2011","unstructured":"Bartels T, Choi JG, Selkoe DJ (2011) \u03b1-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477(7362):107\u2013110. https:\/\/doi.org\/10.1038\/nature10324","journal-title":"Nature"},{"issue":"43","key":"3193_CR160","doi-asserted-by":"publisher","first-page":"17797","DOI":"10.1073\/pnas.1113260108","volume":"108","author":"W Wang","year":"2011","unstructured":"Wang W, Perovic I, Chittuluru J, Kaganovich A, Nguyen LT, Liao J et al (2011) A soluble \u03b1-synuclein construct forms a dynamic tetramer. Proc Natl Acad Sci U S A 108(43):17797\u201317802. https:\/\/doi.org\/10.1073\/pnas.1113260108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"40","key":"3193_CR161","doi-asserted-by":"publisher","first-page":"E4274","DOI":"10.1073\/pnas.1416598111","volume":"111","author":"J Burr\u00e9","year":"2014","unstructured":"Burr\u00e9 J, Sharma M, S\u00fcdhof TC (2014) \u03b1-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation. Proc Natl Acad Sci U S A 111(40):E4274\u2013E4283. https:\/\/doi.org\/10.1073\/pnas.1416598111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3193_CR162","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1750-1326-7-42","volume":"7","author":"KM Danzer","year":"2012","unstructured":"Danzer KM, Kranich LR, Ruf WP, Cagsal-Getkin O, Winslow AR et al (2012) Exosomal cell-to-cell transmission of alpha-synuclein oligomers. Mol Neurodegener 7:42. https:\/\/doi.org\/10.1186\/1750-1326-7-42","journal-title":"Mol Neurodegener"},{"issue":"5","key":"3193_CR163","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"JY Li","year":"2008","unstructured":"Li JY, Englund E, Holton JL, Soulet D, Hagell P et al (2008) Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat Med 14(5):501\u2013503. https:\/\/doi.org\/10.1038\/nm1746","journal-title":"Nat Med"},{"issue":"38","key":"3193_CR164","doi-asserted-by":"publisher","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","volume":"112","author":"SB Prusiner","year":"2015","unstructured":"Prusiner SB, Woerman AL, Mordes DA, Watts JC, Rampersaud R et al (2015) Evidence for \u03b1-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci USA 112(38):E5308\u2013E5317. https:\/\/doi.org\/10.1073\/pnas.1514475112","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2\u20133","key":"3193_CR165","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0014-5793(02)02359-1","volume":"514","author":"VN Uversky","year":"2002","unstructured":"Uversky VN (2002) Cracking the folding code. Why do some proteins adopt partially folded conformations, whereas other don\u2019t? FEBS letters 514(2\u20133):181\u2013183. https:\/\/doi.org\/10.1016\/S0014-5793(02)02359-1","journal-title":"FEBS letters"},{"issue":"3","key":"3193_CR166","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3390\/biom3030703","volume":"3","author":"BA Silva","year":"2013","unstructured":"Silva BA, Einarsd\u00f3ttir \u00d3, Fink AL, Uversky VN (2013) Biophysical characterization of \u03b1-synuclein and rotenone interaction. Biomolecules 3(3):703\u2013732. https:\/\/doi.org\/10.3390\/biom3030703","journal-title":"Biomolecules"},{"issue":"34","key":"3193_CR167","doi-asserted-by":"publisher","first-page":"23179","DOI":"10.1074\/jbc.M802223200","volume":"283","author":"N Sugeno","year":"2008","unstructured":"Sugeno N, Takeda A, Hasegawa T, Kobayashi M, Kikuchi A et al (2008) Serine 129 phosphorylation of alpha-synuclein induces unfolded protein response-mediated cell death. J Biol Chem 283(34):23179\u201323188. https:\/\/doi.org\/10.1074\/jbc.M802223200","journal-title":"J Biol Chem"},{"issue":"3","key":"3193_CR168","doi-asserted-by":"publisher","first-page":"207","DOI":"10.5607\/en20014","volume":"29","author":"WH Shin","year":"2020","unstructured":"Shin WH, Chung KC (2020) Death-associated protein kinase 1 phosphorylates \u03b1-Synuclein at ser129 and exacerbates rotenone-induced toxic aggregation of \u03b1-Synuclein in dopaminergic SH-SY5Y Cells. Exp Neurobiol 29(3):207\u2013218. https:\/\/doi.org\/10.5607\/en20014","journal-title":"Exp Neurobiol"},{"key":"3193_CR169","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/neuro.24.005.2009","volume":"1","author":"AR Esteves","year":"2010","unstructured":"Esteves AR, Ardu\u00edno DM, Swerdlow RH, Oliveira CR, Cardoso SM (2010) Microtubule depolymerization potentiates alpha-synuclein oligomerization. Front Aging Neurosci 1:5. https:\/\/doi.org\/10.3389\/neuro.24.005.2009","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"3193_CR170","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/0304-4165(78)90315-x","volume":"543","author":"LE Marshall","year":"1978","unstructured":"Marshall LE, Himes RH (1978) Rotenone inhibition of tubulin self-assembly. Biochim Biophys Acta (BBA)-General Subjects 543(4):590\u2013594. https:\/\/doi.org\/10.1016\/0304-4165(78)90315-x","journal-title":"Biochim Biophys Acta (BBA)-General Subjects"},{"issue":"1","key":"3193_CR171","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neuroscience.2005.01.044","volume":"133","author":"FJ D\u00edaz-Corrales","year":"2005","unstructured":"D\u00edaz-Corrales FJ, Asanuma M, Miyazaki I, Miyoshi K, Ogawa N (2005) Rotenone induces aggregation of \u03b3-tubulin protein and subsequent disorganization of the centrosome: relevance to formation of inclusion bodies and neurodegeneration. Neuroscience 133(1):117\u2013135. https:\/\/doi.org\/10.1016\/j.neuroscience.2005.01.044","journal-title":"Neuroscience"},{"issue":"18","key":"3193_CR172","doi-asserted-by":"publisher","first-page":"4788","DOI":"10.1111\/j.1742-4658.2007.06004.x","volume":"274","author":"P Srivastava","year":"2007","unstructured":"Srivastava P, Panda D (2007) Rotenone inhibits mammalian cell proliferation by inhibiting microtubule assembly through tubulin binding. FEBS J 274(18):4788\u20134801. https:\/\/doi.org\/10.1111\/j.1742-4658.2007.06004.x","journal-title":"FEBS J"},{"key":"3193_CR173","doi-asserted-by":"publisher","unstructured":"Ren Y, Liu W, Jiang Q, Feng J (2005) Selectively vulnerability of dopaminergic neurons to microtubule depolymerization. J Biol Chem 280:34105\u201334112. https:\/\/doi.org\/10.1074\/jbc.M503483200","DOI":"10.1074\/jbc.M503483200"},{"issue":"39","key":"3193_CR174","doi-asserted-by":"publisher","first-page":"15136","DOI":"10.1073\/pnas.0807581105,114","volume":"105","author":"WS Choi","year":"2008","unstructured":"Choi WS, Kruse SE, Palmiter RD, Xia Z (2008) Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat. Proc Natl Acad Sci U S A 105(39):15136\u201315141. https:\/\/doi.org\/10.1073\/pnas.0807581105,114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"3193_CR175","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s12031-021-01876-w","volume":"71","author":"Y Ivashko-Pachima","year":"2021","unstructured":"Ivashko-Pachima Y, Seroogy KB, Sharabi Y, Gozes I (2021) Parkinson disease-modification encompassing rotenone and 6-hydroxydopamine neurotoxicity by the microtubule-protecting drug candidate SKIP. J Mol Neurosci 71(8):1515\u20131524. https:\/\/doi.org\/10.1007\/s12031-021-01876-w","journal-title":"J Mol Neurosci"},{"issue":"3","key":"3193_CR176","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1471-4159.2010.06631.x","volume":"113","author":"AR Esteves","year":"2010","unstructured":"Esteves AR, Lu J, Rodova M, Onyango I, Lezi E et al (2010) Mitochondrial respiration and respiration-associated proteins in cell lines created through Parkinson\u2019s subject mitochondrial transfer. J Neurochem 113(3):674\u2013682. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06631.x","journal-title":"J Neurochem"},{"issue":"24","key":"3193_CR177","doi-asserted-by":"publisher","first-page":"10192","DOI":"10.1158\/0008-5472.CAN-10-2429","volume":"70","author":"EN Maldonado","year":"2010","unstructured":"Maldonado EN, Patnaik J, Mullins MR, Lemasters JJ (2010) Free tubulin modulates mitochondrial membrane potential in cancer cells. Cancer Res 70(24):10192\u201310201. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2429","journal-title":"Cancer Res"},{"issue":"5","key":"3193_CR178","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1083\/jcb.201009132.Choi","volume":"192","author":"WS Choi","year":"2011","unstructured":"Choi WS, Palmiter RD (2011) Xia Z (2011) Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson\u2019s disease model. J Cell Biol 192(5):873\u2013882. https:\/\/doi.org\/10.1083\/jcb.201009132.Choi","journal-title":"J Cell Biol"},{"key":"3193_CR179","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.874596","volume":"10","author":"IH Fl\u00f8nes","year":"2022","unstructured":"Fl\u00f8nes IH, Tzoulis C (2022) Mitochondrial respiratory chain dysfunction-a hallmark pathology of idiopathic Parkinson\u2019s disease? Front Cell Dev Biol 10:874596. https:\/\/doi.org\/10.3389\/fcell.2022.874596","journal-title":"Front Cell Dev Biol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-03193-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-022-03193-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-03193-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T03:18:10Z","timestamp":1677813490000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-022-03193-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,3]]},"references-count":179,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["3193"],"URL":"https:\/\/doi.org\/10.1007\/s12035-022-03193-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,3]]},"assertion":[{"value":"29 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript does not report the results of studies involving humans and\/or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"This manuscript does not involve human subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"This manuscript does not involve human subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}